Miguel Medina

Noscira SA develops and manufactures pharmaceutical products. It focuses on developing drugs for the treatment of nervous system disorders, especially the Alzheimer's disease. The company was founded in 2000 and is headquartered in Tres Cantos, Spain

Noscira SA develops and manufactures pharmaceutical products. It focuses on developing drugs for the treatment of nervous system disorders, especially the Alzheimer's disease. The company was founded in 2000 and is headquartered in Tres Cantos, Spain

Part of JB Capital Markets Sociedad de Valores SA, JB Capital Markets SV SA (UK) is a leading independent firm based in London, UK. The firm offers a wide range of financial services, including research, brokerage, and advisory in equities and fixed income, as well as financial and management services in investment banking, energy & infrastructures, principal investments, SME lending, and NPLs. With a deep local presence and extensive international experience, the team provides a high-value added proposal for the firm's institutional client base. The British company's website uses cookies to improve user experience while navigating through the website. Christopher T. Cooper has been the CEO of the company since 2010.

Noscira SA develops and manufactures pharmaceutical products. It focuses on developing drugs for the treatment of nervous system disorders, especially the Alzheimer's disease. The company was founded in 2000 and is headquartered in Tres Cantos, Spain

Part of JB Capital Markets Sociedad de Valores SA, JB Capital Markets SV SA (UK) is a leading independent firm based in London, UK. The firm offers a wide range of financial services, including research, brokerage, and advisory in equities and fixed income, as well as financial and management services in investment banking, energy & infrastructures, principal investments, SME lending, and NPLs. With a deep local presence and extensive international experience, the team provides a high-value added proposal for the firm's institutional client base. The British company's website uses cookies to improve user experience while navigating through the website. Christopher T. Cooper has been the CEO of the company since 2010.

Noscira SA develops and manufactures pharmaceutical products. It focuses on developing drugs for the treatment of nervous system disorders, especially the Alzheimer's disease. The company was founded in 2000 and is headquartered in Tres Cantos, Spain